GOLGA6FP: A Potential Drug Target and Biomarker for Diseases (G645752)

Target Name: GOLGA6FP

NCBI ID: G645752

GOLGA6FP

Other Name(s): golgin A6 family member F, pseudogene | Golgin A6 family member F, pseudogene

GOLGA6FP: A Potential Drug Target and Biomarker for Diseases

GOLGA6FP, also known as golgin A6 family member F, is a protein that is expressed in various tissues and cells throughout the body. It is a member of the Golgi complex, which is a network of protein-protein interactions that plays a crucial role in the proper functioning of cells. GOLGA6FP has been identified as a potential drug target and may also be a biomarker for certain diseases.

The Golgi complex is a complex network of protein-protein interactions that is responsible for many different functions in the cell. It is made up of a large number of different proteins that work together to break down and process various types of molecules, including proteins, lipids, and carbohydrates. The Golgi complex is also responsible for the production and modification of many different proteins, which are then released into the cytoplasm to perform various functions in the cell.

One of the proteins that is a part of the Golgi complex is GOLGA6FP. This protein is a member of the Golgi A6 family, which is a group of proteins that are characterized by their ability to interact with the protein transmembrane receptor tyrosine. GOLGA6FP is a 21-kDa protein that is expressed in a variety of tissues and cells, including brain, heart, and pancreas.

GOLGA6FP has been shown to play a role in many different processes in the cell. For example, it has been shown to be involved in the regulation of cell signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and progression of many different diseases.

In addition to its role in cell signaling pathways, GOLGA6FP has also been shown to be involved in the regulation of cell adhesion. Adhesion is the process by which cells stick together and form tissues, and is a critical factor in the development and maintenance of tissues and organs. GOLGA6FP has been shown to be involved in the regulation of cell adhesion by interacting with the protein E-cadherin.

GOLGA6FP has also been shown to be involved in the regulation of cell migration. Migration is the process by which cells move from one location to another in the body, and is a critical factor in the development and progression of many different diseases. GOLGA6FP has been shown to be involved in the regulation of cell migration by interacting with the protein aldose protein.

In addition to its role in cell signaling pathways, GOLGA6FP has also been shown to be involved in the regulation of cell apoptosis. Apoptosis is the process by which cells die, and is a natural and important part of the immune response. GOLGA6FP has been shown to be involved in the regulation of cell apoptosis by interacting with the protein Bcl-2.

GOLGA6FP has also been shown to be involved in the regulation of cell cycle progression. The cell cycle is the process by which cells grow and divide, and is a critical factor in the development and progression of many different diseases. involved in the regulation of cell cycle progression by interacting with the protein p21.

In addition to its role in cell signaling pathways, GOLGA6FP has also been shown to be involved in the regulation of cell transcriptional factors. Transcriptional factors are proteins that regulate the production of RNA from DNA, and play a crucial role in the regulation of gene expression . GOLGA6FP has been shown to be involved in the regulation of cell transcriptional factors by interacting with the protein

Protein Name: Golgin A6 Family Member F, Pseudogene

The "GOLGA6FP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GOLGA6FP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets